Trial Profile
A Phase I, Open-Label, Randomized, Crossover Trial in Healthy Adults to Compare the Oral Bioavailability of TMC278 From Three Concept Pediatric Formulations (Solution, Suspension, Granules) With That From the Adult Phase III Tablet Formulation.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Apr 2011
Price :
$35
*
At a glance
- Drugs Rilpivirine (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Janssen R&D Ireland
- 23 May 2009 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
- 23 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Jan 2009 Actual start date (Jan 2009) added as reported by ClinicalTrials.gov.